Mesa Laboratories Inc /CO earnings releases MLAB

Mesa Laboratories Inc /CO last reported quarterly results on Aug 10, 2026, for Q1 FY2027 (the quarter ended Jun 30, 2026): revenue of $60.1 million and diluted EPS of $0.49. It usually reports 34–57 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 5, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 34–57 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 10, 2026
41 days after quarter end
Q1 FY2027
ended Jun 30, 2026
60
3
0.49
May 27, 2026
57 days after quarter end
Q4 FY2025
ended Mar 31, 2026
—
—
—
Feb 3, 2026
34 days after quarter end
Q3 FY2025
ended Dec 31, 2025
—
—
—
Nov 6, 2025
37 days after quarter end
Q2 FY2025
ended Sep 30, 2025
—
—
—
Aug 5, 2025
36 days after quarter end
Q1 FY2025
ended Jun 30, 2025
60
+17.6%
5
+963.8%
0.85
+950.0%
May 28, 2025
58 days after quarter end
Q4 FY2025
ended Mar 31, 2025
62
+5.5%
-7
+97.2%
-1.34
+97.2%
Feb 4, 2025
35 days after quarter end
Q3 FY2025
ended Dec 31, 2024
63
+17.5%
-2
-179.2%
-0.31
-179.5%
Nov 7, 2024
38 days after quarter end
Q2 FY2025
ended Sep 30, 2024
58
+8.8%
3
+378.7%
0.63
+373.9%

Company profile

Industry
Industrial Instruments For Measurement, Display, and Control (SIC 3823)
Listed as
MLAB (Nasdaq)
Fiscal year ends
March 31
Incorporated in
CO
Headquarters
Lakewood, CO
SEC filer status
Accelerated filer
SEC CIK
724004
Former names
MESA LABORATORIES INC /CO (until Aug 28, 2020)

Other Industrial Instruments For Measurement, Display, and Control companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.